Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
Cynthia Matossian,1 William Trattler,2 Jennifer Loh3 1Matossian Eye Associates, Pennington, NJ, USA; 2Center for Excellence in Eye Care, Miami, FL, USA; 3Loh Ophthalmology Associates, Miami, FL, USACorrespondence: Cynthia MatossianMatossian Eye Associates, 2 Capital Way, Ste 326, Pennington, NJ, 085...
Main Authors: | Matossian C, Trattler W, Loh J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/dry-eye-treatment-with-topical-cyclosporine-01-in-chondroitin-sulfate--peer-reviewed-fulltext-article-OPTH |
Similar Items
-
Topical Cyclosporine A 0.05% for the Treatment of Dry Eye Disease
by: Naeima M. Elzlitni, et al.
Published: (2021-03-01) -
Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
by: Deveney T, et al.
Published: (2018-03-01) -
Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
by: Yuan-Hsi Chan, et al.
Published: (2023-01-01) -
Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
by: Rhee MK, et al.
Published: (2017-06-01) -
Short-Term Efficacy of Ophthalmic Cyclosporine: A 0.1% Cationic Emulsion in Dry Eye Patients Assessed Under Controlled Environment
by: Laura Valencia-Nieto, et al.
Published: (2024-03-01)